12/05/2020.
Over the past six months, an increasing number of colleagues, clients and prospects have asked us how our proVizor platform can assist clinicians and patients deal with covid. Simply, we don’t know enough about covid or the evidence-based practices that could be expressed through the proVizor platform.
We’ve set up this section of our Research tab to post what we are learning as we travel together through this global pandemic.
Below is our first post under this COVID heading, containing Doug’s notes from an NIH sponsored workship on Post-Acute (long term) Sequelae (manifestations and complications) of COVID-19, which was conducted on December 3 & 4, 2020. We will add other content as we study the needs of those suffering from COVID.
On Thursday and Friday, December 3 & 4, the National Institute of Health (NIH) hosted a workshop on the long term (post-acute) manifestations and consequences (sequelae) of COVID-19. The workshop started with 4 questions:
1) What is post-acute COVID?
2) What do we know about it?
3) Where are knowledge gaps?
4) What are the next high-priority areas for research?
